Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,414 | -3,358 | -3,765 | -1,856 | -1,917 |
| Depreciation Amortization | 804 | 806 | 8 | 25 | 1 |
| Income taxes - deferred | -1,001 | -603 | -903 | N/A | N/A |
| Accounts payable and accrued liabilities | 245 | -217 | 241 | 10 | 4 |
| Other Working Capital | -140 | -180 | 189 | 161 | -239 |
| Other Operating Activity | 11,363 | 801 | 521 | 5 | -4 |
| Operating Cash Flow | $-3,143 | $-2,750 | $-3,708 | $-1,655 | $-2,155 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,019 | -1,019 |
| PPE Investments | N/A | N/A | N/A | -21 | -24 |
| Net Acquisitions | N/A | N/A | N/A | 6 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -22 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -22 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-22 | $1,005 | $-1,043 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 863 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 805 | N/A | 2,580 | N/A |
| Common Stock Issued | 17,101 | N/A | 2,875 | N/A | 4,270 |
| Other Financing Activity | -95 | 896 | -251 | -155 | 0 |
| Financing Cash Flow | $17,868 | $1,701 | $2,624 | $2,425 | $4,270 |
| Beginning Cash Position | 692 | 1,741 | 2,847 | 1,072 | N/A |
| End Cash Position | 15,416 | 692 | 1,741 | 2,847 | 1,072 |
| Net Cash Flow | $14,725 | $-1,049 | $-1,107 | $1,776 | $1,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,143 | -2,750 | -3,708 | -1,655 | -2,155 |
| Capital Expenditure | N/A | N/A | N/A | -21 | -24 |
| Free Cash Flow | -3,143 | -2,750 | -3,708 | -1,675 | -2,179 |